Molecular Profiling of the Residual Disease of Triple-Negative Breast Cancers After Neoadjuvant Chemotherapy Identifies Actionable Therapeutic Targets
Cancer Discovery - United States
doi 10.1158/2159-8290.cd-13-0286
Full Text
Open PDFAbstract
Available in full text
Categories
Date
December 19, 2013
Authors
Publisher
American Association for Cancer Research (AACR)